A636P testing in Ashkenazi Jews

G. Jose, G. Harvey, Palmer Crystal, Glogowski Emily, Rob Finch, Nafa Khedoudja, J. Arnold, Offit Kenneth, Nathan Ellis

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited colorectal cancer syndrome attributable to mutations in one of several DNA mismatch repair genes, most commonly MLH1 and MSH2. In certain populations, founder mutations account for a substantial portion of HNPCC. In this report we summarize the literature and our personal experience testing for a specific founder mutation in the Ashkenazi Jewish population, MSH2*1906G>C, also known as A636P. Although rare in the general population, the A636P mutation is detected in up to 7% of Ashkenazi Jewish patients with early age-of-onset colorectal cancer, and may account for up to one third of HNPCC in the Ashkenazi Jewish population. In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation.

Original languageEnglish (US)
Pages (from-to)223-227
Number of pages5
JournalFamilial Cancer
Volume3
Issue number3-4
DOIs
StatePublished - 2004
Externally publishedYes

Fingerprint

Jews
Hereditary Nonpolyposis Colorectal Neoplasms
Mutation
Population
Colorectal Neoplasms
DNA Mismatch Repair
Age of Onset
Genes

Keywords

  • A636P
  • Ashkenazi Jewish
  • hereditary nonpolyposis colorectal cancer
  • mismatch repair

ASJC Scopus subject areas

  • Genetics
  • Oncology
  • Genetics(clinical)
  • Cancer Research

Cite this

Jose, G., Harvey, G., Crystal, P., Emily, G., Finch, R., Khedoudja, N., ... Ellis, N. (2004). A636P testing in Ashkenazi Jews. Familial Cancer, 3(3-4), 223-227. https://doi.org/10.1007/s10689-004-0899-z

A636P testing in Ashkenazi Jews. / Jose, G.; Harvey, G.; Crystal, Palmer; Emily, Glogowski; Finch, Rob; Khedoudja, Nafa; Arnold, J.; Kenneth, Offit; Ellis, Nathan.

In: Familial Cancer, Vol. 3, No. 3-4, 2004, p. 223-227.

Research output: Contribution to journalArticle

Jose, G, Harvey, G, Crystal, P, Emily, G, Finch, R, Khedoudja, N, Arnold, J, Kenneth, O & Ellis, N 2004, 'A636P testing in Ashkenazi Jews', Familial Cancer, vol. 3, no. 3-4, pp. 223-227. https://doi.org/10.1007/s10689-004-0899-z
Jose G, Harvey G, Crystal P, Emily G, Finch R, Khedoudja N et al. A636P testing in Ashkenazi Jews. Familial Cancer. 2004;3(3-4):223-227. https://doi.org/10.1007/s10689-004-0899-z
Jose, G. ; Harvey, G. ; Crystal, Palmer ; Emily, Glogowski ; Finch, Rob ; Khedoudja, Nafa ; Arnold, J. ; Kenneth, Offit ; Ellis, Nathan. / A636P testing in Ashkenazi Jews. In: Familial Cancer. 2004 ; Vol. 3, No. 3-4. pp. 223-227.
@article{6da0568083544338a1f349d830bb17ab,
title = "A636P testing in Ashkenazi Jews",
abstract = "Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited colorectal cancer syndrome attributable to mutations in one of several DNA mismatch repair genes, most commonly MLH1 and MSH2. In certain populations, founder mutations account for a substantial portion of HNPCC. In this report we summarize the literature and our personal experience testing for a specific founder mutation in the Ashkenazi Jewish population, MSH2*1906G>C, also known as A636P. Although rare in the general population, the A636P mutation is detected in up to 7{\%} of Ashkenazi Jewish patients with early age-of-onset colorectal cancer, and may account for up to one third of HNPCC in the Ashkenazi Jewish population. In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation.",
keywords = "A636P, Ashkenazi Jewish, hereditary nonpolyposis colorectal cancer, mismatch repair",
author = "G. Jose and G. Harvey and Palmer Crystal and Glogowski Emily and Rob Finch and Nafa Khedoudja and J. Arnold and Offit Kenneth and Nathan Ellis",
year = "2004",
doi = "10.1007/s10689-004-0899-z",
language = "English (US)",
volume = "3",
pages = "223--227",
journal = "Familial Cancer",
issn = "1389-9600",
publisher = "Springer Netherlands",
number = "3-4",

}

TY - JOUR

T1 - A636P testing in Ashkenazi Jews

AU - Jose, G.

AU - Harvey, G.

AU - Crystal, Palmer

AU - Emily, Glogowski

AU - Finch, Rob

AU - Khedoudja, Nafa

AU - Arnold, J.

AU - Kenneth, Offit

AU - Ellis, Nathan

PY - 2004

Y1 - 2004

N2 - Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited colorectal cancer syndrome attributable to mutations in one of several DNA mismatch repair genes, most commonly MLH1 and MSH2. In certain populations, founder mutations account for a substantial portion of HNPCC. In this report we summarize the literature and our personal experience testing for a specific founder mutation in the Ashkenazi Jewish population, MSH2*1906G>C, also known as A636P. Although rare in the general population, the A636P mutation is detected in up to 7% of Ashkenazi Jewish patients with early age-of-onset colorectal cancer, and may account for up to one third of HNPCC in the Ashkenazi Jewish population. In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation.

AB - Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominantly inherited colorectal cancer syndrome attributable to mutations in one of several DNA mismatch repair genes, most commonly MLH1 and MSH2. In certain populations, founder mutations account for a substantial portion of HNPCC. In this report we summarize the literature and our personal experience testing for a specific founder mutation in the Ashkenazi Jewish population, MSH2*1906G>C, also known as A636P. Although rare in the general population, the A636P mutation is detected in up to 7% of Ashkenazi Jewish patients with early age-of-onset colorectal cancer, and may account for up to one third of HNPCC in the Ashkenazi Jewish population. In addition, we summarize our initial experience with a prospective A636P testing protocol aimed at Ashkenazi Jewish patients at high or intermediate risk for harboring the A636P mutation.

KW - A636P

KW - Ashkenazi Jewish

KW - hereditary nonpolyposis colorectal cancer

KW - mismatch repair

UR - http://www.scopus.com/inward/record.url?scp=8544276607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=8544276607&partnerID=8YFLogxK

U2 - 10.1007/s10689-004-0899-z

DO - 10.1007/s10689-004-0899-z

M3 - Article

VL - 3

SP - 223

EP - 227

JO - Familial Cancer

JF - Familial Cancer

SN - 1389-9600

IS - 3-4

ER -